Live Breaking News & Updates on Sentinel Surveillance Data

Stay updated with breaking news from Sentinel surveillance data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda's QDENGA▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

08.12.2022 - Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) granted marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in . ....

Sri Lanka , United States , Dominican Republic , Takeda Yakuhin Kogyo , Tomas Jelinek , World Health Organization , Berlin Centre For , Data Monitoring Committee , Exchange Commission , European Union Eu Member States , Takeda Pharmaceutical Company Limited , European Centre For Disease Prevention , Medical Director , Berlin Centre , Tropical Medicine , Scientific Director , Dengue Efficacy Study , Fiscal Year , European Union , Member States , Product Characteristics , Latin America , Rare Genetics , Plasma Derived Therapies , Pharmaceutical Company Limited , Annual Report ,

Takeda Pharmaceutical Company Limited: Takeda's QDENGA? (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission Approved QDENGA (TAK-003) for Use in Individuals Four Years of Age and Olderi QDENGA Becomes the Only Dengue Vaccine Approved in the EU for Use in Individuals Regardless of Previous ....

Sri Lanka , United States , Dominican Republic , Gary Dubin , Rachel Higgins , Tomas Jelinek , Jun Saito , European Commission , World Health Organization , International Media , Berlin Centre For , Data Monitoring Committee , Exchange Commission , European Commission Approved , European Union Eu Member States , European Union , Takeda Pharmaceutical Company Limited , European Centre For Disease Prevention , Individuals Four Years , Only Dengue Vaccine Approved , Individuals Regardless , Previous Dengue , Dengue Tetravalent Vaccine , European Medicines Agency , Medicinal Products , Human Use ,